Home - Products - Others - Other Targets - ((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine

((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine

CAS No. 676129-92-3

((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine( ——— )

Catalog No. M39563 CAS No. 676129-92-3

Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 526 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ((2-(1H-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-L-valine
  • Note
    Research use only, not for human use.
  • Brief Description
    Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.
  • Description
    Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    676129-92-3
  • Formula Weight
    351.4
  • Molecular Formula
    C19H21N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 250 mg/mL (711.44 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. A Sampath, et al. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist. J Pharm Biomed Anal. 2009 Oct 15;50(3):405-12.?
molnova catalog
related products
  • Tibesaikosaponin V

    Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.

  • GPI-1485

    GPI-1485 (GM1485) is a nonimmunosuppressive immunophilin ligand, promoting neurofunctional improvement and neural regeneration following stroke.

  • AA92593

    AA92593 has been used as a selective inhibitor of melanopsin.The involvement of melanopsin in the regulation of melatonin was also determined by using a specific inhibitor AA92593 and by inhibiting melanopsin-induced phospholipase C activation.